Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Adhezion seals deal on more funds for series A

This article was originally published in Clinica

Executive Summary

Adhezion Biomedical, a Wyomissing, Pennsylvania-based developer of cyanoacrylate-based medical adhesives and antimicrobial sealants, has raised an additional $2.1m in series A financing, bringing the total investment received to $5.25m. The second tranche of funds came from Liberty Venture Partners. Adhezion’s flagship product is SurgiSeal, which is being introduced to European markets and is pending US FDA approval. Other products in the pipeline include DermaSeal, a woundcare product, and FloraSeal, an advancedantimicrobial sealant.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT041526

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel